All In MedTech

Device Trial Radar · NCT04829058

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

A Retrospective and Long-Term Prospective Post Market Clinical Follow-up (PMCF) Study of the GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

64

Actual

Start

Nov 24, 2021

Primary completion

Jun 24, 2026

Study completion Jun 24, 2026

Sponsor

Lead sponsor
Ethicon, Inc.Public (JNJ)
Sponsor type
Industry
First posted
Apr 2, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Female only, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse with a GYNEMESH PS Mesh.

Conditions

  • Pelvic Organ Prolapse

Interventions

  • InterventionDevice

    There is no intervention, beyond necessary clinical care, in this study. The surgical procedures that were performed in subjects within this study are identical to the surgical procedures the subjects would have received as part of SOC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Physical examination with Pelvic Organ Prolapse Quantification (POP-Q) Assessment CHangeTime frame: Post-surgery through study completion, approximately 7 yrs

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Institute for Female Pelvic Medicine

    North Wales, Pennsylvania

  • UMPC

    Pittsburgh, Pennsylvania

  • Universitatsklinikum Tubingen

    Tübingen, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.